SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-24-044069
Filing Date
2024-05-16
Accepted
2024-05-16 10:25:53
Documents
2
Group Members
ALPHA PHARMA INVESTMENTS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea0206277-13gsoffer_gale.htm SC 13G 58768
2 JOINT FILING AGREEMENT ea020627701ex99-1_gale.htm EX-99.1 4622
  Complete submission text file 0001213900-24-044069.txt   64766
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91201 | Film No.: 24953899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9559 COLLINS AVENUE #1009S MIAMI FL 33154
Business Address
Soffer Rochel (Filed by) CIK: 0002023129 (see all company filings)

Type: SC 13G